Skip to content
Home
Close Home
Open Home
Journal information
Editorial board
Operations manual
Editorial policies
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Close Read
Open Read
Archive
TOC Alert
Current issue
Information
Close Information
Open Information
Editorial & Peer Review
Ethical policies
Funding
Complaints and appeals
Open access and licensing
Authors
Sponsorship
Contact
Publish
Close Publish
Open Publish
Instructions to authors
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
Home
Journal Information
Editorial Board
Operations Manual
Editorial Polices
Code of conduct for authors
Code of conduct for reviewers
Ahead of print
Read
Archive
Toc Alert
Current issue
Information
Editorial & Peer review
Ethical policies
Funding
Procedure for complaints and/or appeals
Open access & Licensing
Authors
Sponsors
Contact
Publish
Authors Instructions
Online submission
ES
EN
0,00
€
0
Cart
TOC Alert
Author:
creacionmx
Entry Inhibitors come of Age
A Codon T69SSS Insertion Causes Resistance to Multiple Nucleoside Analogues
HIV Guidelines
Initiating HAART at the DHHS Guidelines (February 4, 2002): Just do it, but Much Later!
Putting the Brakes on drug Approval: Adefovir
Salvage Therapy – Hope or Despair?
Mechanisms of Resistance to Nucleosides Unraveled
Interferon Plus Ribavirin for Chronic Hepatitis C in HIV-infected Persons
What is the Source of Viral Rebound after Cessation of HAART?
Cardiovascular Risk of Antiretroviral Therapy
←
previous
Next
→